Subsite specificity of the proteinase from myeloblastosis associated virus
- PMID: 2026269
- DOI: 10.1016/0014-5793(91)80447-b
Subsite specificity of the proteinase from myeloblastosis associated virus
Abstract
The subsite requirements of the aspartic proteinase from the myeloblastosis-associated virus (MAV) for the cleavage of peptide substrates were studied with a series of synthetic peptides of general structure Ala-Thr-P4-P3-P2-P1*Nph-Val-Arg-Lys-Ala. The residues in positions P4, P3, P2 and P1 were varied and the kinetic parameters for the cleavage of substrates in 2.0 M NaCl were spectrophotometrically determined at pH 6.0 and 37 degrees C. The acceptance of amino acid residues in particular subsites is similar to that observed with the human immunodeficiency virus type 1 (HIV-1) proteinase in our earlier studies on the same substrate series: hydrophobic or aromatic residues are preferable in P1 position, a broad variety of residues are acceptable in P3 whereas the residues occupying P2 plays the decisive role in the substrate cleavage as evidenced by its dramatic influence on both kcat and Km values. The most remarkable difference between the two enzymes was found in P3 and P4 subsites. In P3, the introduction of negatively charged glutamate increases the substrate binding by the MAV proteinase 12-fold and decreases binding by the HIV-1 proteinase. In P4, Pro in this series is a favourable residue for the MAV proteinase and is strongly inacceptable for HIV-1 the proteinase. The pH profile of the cleavage was studied with a chromogenic substrate and differences between HIV-1 and MAV proteinases are discussed.
Similar articles
-
Specificity studies on retroviral proteinase from myeloblastosis-associated virus.Biochemistry. 1991 Apr 9;30(14):3437-43. doi: 10.1021/bi00228a013. Biochemistry. 1991. PMID: 1849425
-
Sub-site preferences of the aspartic proteinase from the human immunodeficiency virus, HIV-1.FEBS Lett. 1990 Jul 30;268(1):35-8. doi: 10.1016/0014-5793(90)80966-m. FEBS Lett. 1990. PMID: 2200711
-
15gag proteinase of myeloblastosis-associated virus: specificity studies with substrate-based inhibitors.Arch Biochem Biophys. 1992 Nov 1;298(2):753-6. doi: 10.1016/0003-9861(92)90476-d. Arch Biochem Biophys. 1992. PMID: 1417001
-
Subsite preferences of pepstatin-insensitive carboxyl proteinases from bacteria.J Biochem. 1999 Jan;125(1):75-81. doi: 10.1093/oxfordjournals.jbchem.a022271. J Biochem. 1999. PMID: 9880800
-
Kinetic and modeling studies of S3-S3' subsites of HIV proteinases.Biochemistry. 1992 May 26;31(20):4793-800. doi: 10.1021/bi00135a008. Biochemistry. 1992. PMID: 1591240
Cited by
-
Characterization of the protease of a fish retrovirus, walleye dermal sarcoma virus.J Virol. 2002 May;76(9):4341-9. doi: 10.1128/jvi.76.9.4341-4349.2002. J Virol. 2002. PMID: 11932400 Free PMC article.
-
An engineered retroviral proteinase from myeloblastosis associated virus acquires pH dependence and substrate specificity of the HIV-1 proteinase.EMBO J. 1992 Mar;11(3):1141-4. doi: 10.1002/j.1460-2075.1992.tb05154.x. EMBO J. 1992. PMID: 1547777 Free PMC article.
-
Importance of the N terminus of rous sarcoma virus protease for structure and enzymatic function.J Virol. 2001 May;75(10):4761-70. doi: 10.1128/JVI.75.10.4761-4770.2001. J Virol. 2001. PMID: 11312348 Free PMC article.
-
Analysis of cleavage site mutations between the NC and PR Gag domains of Rous sarcoma virus.J Virol. 1997 Jan;71(1):444-50. doi: 10.1128/JVI.71.1.444-450.1997. J Virol. 1997. PMID: 8985369 Free PMC article.
-
Kinetics of the dimerization of retroviral proteases: the "fireman's grip" and dimerization.Protein Sci. 2003 Oct;12(10):2173-82. doi: 10.1110/ps.03171903. Protein Sci. 2003. PMID: 14500875 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources